Because LACTB was shown previously to exert tumor suppressor properties in cancers of epithelial origin, we focused our attention on analyzing the two types of ovary adenocarcinomas: mucinous and serous, which belong to type I and type II of ovarian cancers, respectively. Here, LACTB is linked to cancer.